Diagonal Paraguay 362, Piso 7, Escuela de Medicina UC contacto@cendhy.cl
  • Facebook
  • X
  • Instagram
  • Facebook
  • X
  • Instagram
  • Español
  • English
Cendhy, centro de nuevos fármacos para hipertensión e insuficiencia cardíaca
  • Home
  • ABOUT US
    • Principal Researchers
    • Associated Researchers
    • INTERNATIONAL COLLABORATORS
    • Mission and Vision
    • Communications
    • Postdoctoral researchers
  • Research
    • Research objectives
    • Publications
  • Outreach
    • CALENDAR
    • PROJECTS
    • DOWNLOADABLE
  • BLOG
  • PRESS
Select Page
Who is affected?

Who is affected?

by Cendhy | Apr 15, 2020 | Blog

Nobody is saved In the absence of other conditions that affect health, high blood pressure develops over the course of many years and affects almost everyone at an advanced age. In Chile more than 11% of the population is over 65 years old, and 33% of the total is...
Next Entries »

Últimas publicaciones

  • CENDHY Director receives 2015 ASILFA Prize 4 January 2022
  • Most recent evidence on the use of ACE Inhibitors and ARBs on COVID-19 patients 20 September 2020
  • Pharmaceutical technology developed by CENDHY director is recognized in national innovation contest 20 September 2020
  • “Nanomedicine: small solutions for giant issues” 1 September 2020
  • CENDHY deputy director interviewed in hometown-based radio 21 August 2020
  • CENDHY researcher gives practical advice on how to improve cardiovascular health 17 August 2020
  • CENDHY researcher explains there is a direct link between COVID-19 and how hypertensive patients respond 28 July 2020
  • CENDHY director was interviewed on radio station from Punta Arenas 28 July 2020
  • Continuing education to the medical community: CENDHY participated in an online congress of the Chilean Society of Hypertension and SAVAL 21 July 2020
  • New research center on hypertension is established at the University of Chile 13 July 2020